# Li Xianxian

> Li Xianxian is a Series A investor at Kaitai Capital backing Medical and Oncology. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Kaitai Capital](https://shizune.co/investors/profile/kaitai-capital)
- Total investments: 1
- Last investment: Nov 2022
- Lead investor: 100%
- Last updated: Aug 2026

Li Xianxian is a Series A investor at Kaitai Capital focused on Medical and Oncology. Li Xianxian

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Oncology | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Lupeng Pharmaceutical | Lupeng Pharmaceutical is a clinical-stage company that focuses on the drug discovery and development of novel therapies for cancer treatment. | $35M | Series A | Nov 14, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Cathay Capital](https://shizune.co/investors/profile/cathaycapital) — VC Fund, 1 deal together
- [FC Capital](https://shizune.co/investors/profile/fc-capital-8330) — VC Fund, 1 deal together
- [Lilly Asia Ventures](https://shizune.co/investors/profile/lilly-asia-ventures) — VC Fund, 1 deal together
- [Qingchi Capital](https://shizune.co/investors/profile/qingchi-capital) — VC Fund, 1 deal together
- [Temasek](https://shizune.co/investors/profile/temasek) — VC Fund, 1 deal together

## About Kaitai Capital

VC Fund · Hangzhou, China

KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management business. Fields of investment include biopharma, healthcare services, agriculture tech, consumer business, digital technology and etc.

5 contacts available at Kaitai Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Huang Zehua | Partner | https://shizune.co/investors/profile/huang-zehua |
| Jin Qi | Managing Partner | https://shizune.co/investors/profile/jin-qi-ef05 |
| Li Xianxian | Managing Partner | https://shizune.co/investors/profile/li-xianxian |
| Nannan Chang | Senior Investment Manager | https://shizune.co/investors/profile/nannan-chang |
| Xian Li | Partner | https://shizune.co/investors/profile/xian-li-67ed |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Li Xianxian invest in?

Li Xianxian invests primarily in Medical, Oncology and Health Care startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Li Xianxian last invest?

The most recent investment recorded for Li Xianxian closed in Nov 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co